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Abstract
Background: Efficient laboratory service is the cornerstone
of modern health care systems. Scientific innovations have
contributed to substantial improvements in the field of lab-
oratory science, but errors still prevail. These errors are
classified as preanalytical, analytical and postanalytical,
depending upon the time of presentation.
Methods: The data for 67,438 routine venous blood speci-
mens were scrutinized, and errors were documented over the
period of 1 year in the clinical biochemistry laboratory of
Govind Ballabh Pant Hospital in Delhi, India.
Results: Preanalytical errors were most common, with a fre-
quency of 77.1% followed by postanalytical 15% and ana-
lytical 7.9%, respectively.
Conclusions: Our study illustrates the importance of proper
venipuncture procedures, analytical expertise and correct
transcription of numerical data for precise and accurate
reporting of results to clinicians. There is an urgent need for
close inter-departmental cooperation to meet the goal of
ensuring patient well being.
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Introduction
Laboratory errors may be defined as ‘‘any defect from order-
ing tests to reporting results and appropriately interpreting
and reacting on these’’ (1). Clinical laboratories have long
focused their attention on quality control (QC) methods and
quality assessment programs dealing with the analytical
Binita Goswami and Bhawna Singh contributed equally to thea
paper.
*Corresponding author: Dr. Bhawna Singh, Assistant Professor,
Department of Biochemistry, GB Pant Hospital, Room No. 418,
Fourth Floor, New Delhi, India
Phone: q91-0-9718599054, E-mail: bhawna172@gmail.com
Received July 28, 2009; accepted September 14, 2009
aspects of testing. However, a growing body of evidence
accumulated in recent decades demonstrates that quality in
clinical laboratories cannot be assured by merely focusing on
analytical aspects only. Pre- and postanalytical processes are
equally important for ensuring quality laboratory service.
Process analysis has demonstrated that laboratory errors
occur primarily in the preanalytic phase, influencing patient
outcomes and costs (1, 2). Literature suggests that preana-
lytical and postanalytical errors account for 93% of the total
errors encountered in the laboratory (3).
Materials and methods
We describe the frequency of preanalytical, analytical and posta-
nalytical errors observed in our clinical chemistry laboratory in
Govind Ballabh Pant Hospital during a 1-year period. Our clinical
biochemistry laboratory serves a 600-beded tertiary hospital. Data
were collected only for hospitalized patients during routine hours.
Our well-equipped laboratory is staffed by individuals that have
undergone mandatory training courses in laboratory techniques.
Since our hospital is preparing for accreditation by the National
Accreditation Board for Hospitals and Healthcare Organizations
(NABH), laboratory technical staff along with the paramedical staff
are regularly undergoing regular training under the aegis of the QC
cell of the hospital. Standard operating procedures (SOPs) for phle-
botomy techniques, patient preparation, sample handling, instrument
handling and maintenance and other aspects of sample processing
have been documented and displayed. Sample analysis is performed
using two fully automated autoanalyzers – OLYMPUS (AU 400,
Tokyo, Japan). Although calibration is performed weekly, calibra-
tion traceability and internal QC is monitored daily. Weekly cali-
brations were performed under the protocol developed by the
Quality Cell in our department. Any drift noted in calibration
requires recalibration of the affected parameter. All ancillary equip-
ment such as auto pipettes, centrifuges and refrigerators are cali-
brated by an authorized central agency at regular intervals.
Preanalytical errors are documented in the laboratory after careful
scrutiny of the samples and the accompanying requisition slips by
laboratory technicians. Preanalytical errors that we encountered
include visible hemolysis after centrifugation, inappropriate volume
(deficit in the volume required to perform the analysis), incorrect
or missing patient identification, inappropriate container and lipemic
samples. Problems encountered during the analytical phase of sam-
ple processing such as non-conformity with QC, random and sys-
temic errors, are also recorded. Postanalytical errors such as
transcription errors and variations in turn around time (TAT) are
documented.
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Table 1 Types and frequency of errors in clinical laboratory.
Type of error Frequency % Cause of error
Preanalytical
Hemolyzed sample 508 53.2 Wrong phlebotomy technique,
incorrect transport centrifugation
before sample is clotted
Insufficient sample 72 7.5 Lack of knowledge regarding
sample volume required,
difficult sampling as in pediatric
and old patients
Lipemic sample 7 0.7 Collection under non-fasting
state? hyperlipidemia
Incorrect identification 44 4.6 Lack of knowledge/lax attitude
Empty tube 10 1.0 of the phlebotomists/staff
Requisition slip without sample 16 1.7 involved in sample collection
Illegible hand writing 69 7.2 and test ordering
Tube broken in the centrifuge 6 0.6 Improper centrifugation
technique
Physician’s request order missed 4 0.4 Carelessness at the level of the
laboratory staff
Total 736 77.1
Analytical
Non-conformity with QC 6 0.6 Old QC, improper storage
Random error 15 1.6 Unknown cause
Calibration drift 10 1.0 Reagent instability, reagent
changeover, expiry of calibration
data with time
Reagent contamination 8 0.4 Reagent mix up, improper storage
Systemic error: probe, lamp, 36 3.8 Inherent technical problem/
blocked tubing routine wear and tear
Total 75 7.9
Postanalytical
Transcription errors 112 11.7 Manual error in copying
numerical data from the printout
on to the requisition slips
Prolonged turn around time 31 3.2 Problem arising due to
inadequate water supply, irregular
electricity, instrument problem
Total 143 14.9
Results
From July 2008 to June 2009, a total of 67,438 routine
venous blood specimens were received in the laboratory.
Errors were detected in 954 samples, with a total error rate
of 1.4%. Preanalytical, analytical, postanalytical phases con-
tributed to 1.1%, 0.1% and 0.2% of errors, respectively. The
contribution of the different phases towards the total number
of errors was 77.1% (preanalytical), 7.9% (analytical) and
15% (postanalytical). We found the highest prevalence of
errors in the preanalytical phase, a total of 736 in the 1-year
observational period (Table 1). Hemolysis was the most com-
mon error due to incorrect procedures for sample collection,
a total of 508 samples being affected. Insufficient volume of
the blood sample drawn was the next most common cause
for unsuitable specimens (72 samples); other common errors
were due to errors in the requisition slip, or due to illegible
hand writing (69 samples), identification errors (44 samples),
empty tubes (10 samples), missing tubes (16 samples) and
tubes broken in the centrifuge (6 samples) (Table 1). Of the
736 samples that showed preanalytical errors, 623 were
rejected (due to hemolysis, lipemia, insufficient quantity,
absent sample and illegible hand writing) contributing to
0.9% of rejections during the 1 year that this analysis was
performed.
In the analytical phase, we identified 75 errors, accounting
for 7.9% of total errors (Table 1). The most frequently detect-
ed analytical problem was due to systemic error (36 events)
followed by random errors (15 events). Other sources of ana-
lytical errors were calibration drift (10 events), contamina-
tion of reagents (8 events), and non-conformity with QC (6
events).
In the postanalytical phase, 143 errors were observed
(Table 1). Transcription errors contributed to the majority of
Goswami et al.: Errors and the laboratory 65
Article in press - uncorrected proof
postanalytical errors (112 requisition slips). Thirty-one
instances of excessive TAT were recorded over the one-year
period.
Discussion
Laboratory services are the backbone of the modern health
care sector. Effective laboratory service is the amalgamation
of precision, accuracy and speed of reports delivered to the
patient. In spite of rapid advances in laboratory science, it is
still susceptible to various manual and systemic errors. Var-
ious types of errors that we, as clinical biochemists, encoun-
ter in the laboratory are classified as preanalytical, analytical
and postanalytical, depending upon the time of presentation.
There is heterogeneous information on the error rate with-
in the whole laboratory testing process, ranging from 0.1%
to 9.3% (1). The distribution of mistakes, as observed by
Plebani and Carraro was: preanalytical 68.2%, analytical
13.3%, and postanalytical 18.5% (4). Evidence from recent
studies demonstrates that a large percentage of laboratory
errors occur in the pre- and post-analytical steps (5–8). Our
findings are in accordance with these studies.
Incorrect phlebotomy practice, lack of knowledge and
non-compliance of the phlebotomist accounts for the major-
ity of preanalytical errors due to hemolysis, inappropriate
sample volume and collection using the incorrect container.
Missing or incompletely filled requisition slips also hamper
sample processing and contribute to preanalytical errors. It
is common knowledge that hemolyzed, lipemic and icteric
samples interfere with the analytical measurement of various
parameters such as glucose, creatinine and cholesterol. The
presence of hemolysis or lipemia resulted in a request for a
fresh sample. However, it was not possible to exclude icteric
samples as our hospital specializes in gastroenterology and
gastrosurgery, and hyperbilirubinemia is common. Thus, all
reports were dispatched with a note cautioning the interpre-
tation of the test results due to accompanying icterus. Infor-
mation concerning drug history was also taken into
consideration when dispatching reports. Our rejection rate
was 0.9%, compared to 1.4% reported by Rico´s et al. (9)
and 0.7% observed by Alsina et al. (10). Hemolyzed samples
were the most commonly encountered problem in our labo-
ratory (53.2%). Of the total samples received in our labora-
tory in 1 year, 0.7% were found to be hemolyzed, compared
to 0.2% reported by Rico´s et al. (9). This can also be
expressed that 81% of the total number of samples rejected
by our laboratory was due to hemolysis. Alsina et al. reported
an incidence of 29.3% of hemolyzed samples in their retro-
spective analysis of data from 105 laboratories (10). The next
most frequent cause of sample rejection was insufficient
sample volume, with frequency of 7.5%. Incomplete patient
information due to illegible hand writing or inappropriately
filled requisition slips (13.9%) interfered with prompt noti-
fication of critical values to the clinician. Other types of pre-
analytical mistakes reported by our laboratory staff were
lipemic samples (0.7%), empty vacutainers (1.0%) and tubes
breaking during centrifugation (0.6%). Of the total number
of samples received during the year, the observed frequency
of incorrect patient identification and illegible handwriting
was 0.1% for both types of errors. This is identical to that
reported by Rico´s et al. (9).
Automation, training of laboratory personnel and adoption
of QC programs has led to an impressive decline in the
occurrence of analytical errors (11–13). We observed a fre-
quency of 7.9% for analytical errors in our clinical labora-
tory. These errors were comprised of systemic errors such as
malfunctioning of probes, photometric lamps and blockage
of tubing, non-conformity with internal QC, random errors
due to pipetting difficulties or the analyzer, or related to pro-
blems such as fibrin clots and short samples, calibration drift,
and contamination of reagents. Systemic errors, which
amounted to 3.8% of the total errors, were the most fre-
quently documented analytical error. Sample processing was
delayed until the problem was identified and rectified by the
service engineer. Random errors due to fibrin clot and other
unidentified causes contributed significantly to analytical
errors (1.6%). Repeat calibration needed to be performed in
ten instances (1.0%), over and above the routine calibrations
that are performed. Abnormal patient results due to calibra-
tion drift was the reason for repeat calibrations. Calibration
of a parameter is considered to be within limits if the optical
density (OD) of the reagent and the factor generated follow-
ing the calibration procedure falls within the range specified
by the manufacturer. New QC material was reconstituted six
times (0.6%) due to abnormal QC results. This can be attrib-
uted to inappropriate storage of QC by the laboratory staff.
Inaccurate results due to reagent contamination were the least
frequent error encountered in our laboratory (0.4%). In our
pursuit for achieving maximum analytical precision and
accuracy, we enrolled our laboratory in two External Quality
Assurance Programs (EQAS). Results are analyzed during
our departmental meetings and any observed shortcomings
addressed on a priority basis. This instills a sense of confi-
dence in our staff.
In the postanalytical phase, the frequency of errors was
15%. Of these, transcription errors accounted for 11.7%. Due
to the lack of a laboratory information system (LIS) in our
hospital, manual transcription of numerical data is prone to
error. Although we double check results in our laboratory,
the risk of transcription error remains. Few results were
released from our laboratory with an excessively prolonged
TAT, 3.2% in frequency due to unforeseen and unavoidable
problems. Rico´s et al. reported that 11% of the samples ana-
lyzed could not be delivered within the specified time limit
(9). Reduction of TAT should improve the quality of service.
Timeliness is most important to the clinician, who may be
prepared to sacrifice analytical quality for faster TAT (14),
but laboratorians prefer to maintain analytical quality as well
as reduce TAT. Apart from delays in the analytical phase,
delayed and lost test requisitions, specimens and reports were
major contributing factors prolonging the TAT. Extensive
labor resources were allocated for locating missing samples/
information.
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Conclusions
The role of clinical laboratories in diagnostic medicine has
been well established. Errors in the laboratory can lead to
inaccurate reports dispatched to clinicians, affecting health
care services greatly. Ensuring the credibility of results is of
utmost importance. While many clinicians probably believe
that most errors in the laboratory are analytical, there are
data showing that the preanalytical and postanalytical phases
are the greatest contributors to laboratory mistakes. Though
it is impossible to completely eliminate errors, it is possible
to reduce them. We conclude that training of phlebotomists
and technicians, bar coding of samples, implementation of a
LIS, adoption of standardized procedures along with partic-
ipation in external quality assessment programs and accred-
itation schemes can help to reduce laboratory errors to a
minimum.
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